featured
Abiraterone Acetate for Metastatic Prostate Cancer Patients With Suboptimal Response to Hormone Induction
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Abiraterone Acetate for Metastatic Prostate Cancer in Patients With Suboptimal Biochemical Response to Hormone Induction
JAMA Oncol 2017 Mar 30;[EPub Ahead of Print], TW Flaig, M Plets, MH Hussain, N Agarwal, N Mitsiades, HA Deshpande, UN Vaishampayan, IM ThompsonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.